Pitt Researchers Leverage AI to Break Leptin Resistance in Obesity Treatment
Researchers at the University of Pittsburgh have unveiled a novel AI-driven approach to obesity drug development focused on restoring leptin sensitivity. This computational method identifies small molecules capable of bypassing leptin resistance, potentially offering a more targeted alternative to current GLP-1 therapies.